Previous 10 | Next 10 |
Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through an innovative pricing program that offers personalized support. This press release features multimedia. View ...
2023-10-29 08:28:00 ET As the calendar turns from October to November, the week promises a flurry of earnings reports from some of the world's most prominent companies. Among the key players stepping into the earnings spotlight will be technology giant Apple ( NASDAQ: AAPL ), semico...
Organon Canada Announces Availability of a High-Concentration, Citrate-Free Formulation of HADLIMA®, a Biosimilar to HUMIRA* Canada NewsWire HADLIMA ® 40 mg/0.4 mL offers a higher concentration compared to HADLIMA ® 40 mg/0.8 mL The availabilit...
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its third quarter 2023 financial results on November 2, 2023, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST. Interested parties may access the live call via...
2023-10-18 10:30:00 ET Summary Miller Value Partners is a value investor. It values businesses, and not just stocks, and invests in them for the long term. The Miller Income Strategy outperformed the ICE BofA High Yield index in Q3 2023, despite the broader decline in securities m...
2023-10-16 14:48:23 ET The market is in very good shape, said Hennessy Funds’ chief market strategist Neil Hennessy. In a CNBC interview on Monday, he pointed out that all three indexes are up. ( DJI ) up 13.07%, compared to last year. ( SP500 ) up 19.13%, compa...
2023-10-16 10:59:42 ET More on Dare Bioscience Seeking Alpha’s Quant Rating on Dare Bioscience Dare Bioscience to sell 10M shares at $0.70 in registered direct offering Historical earnings data for Dare Bioscience For further details see: Daré...
Lululemon Athletica & Hubbell Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Lululemon Athletica & Hubbell Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , Oct....
2023-10-13 17:30:08 ET More on Lululemon, Hubbell, Organon Nike Vs. Lululemon: One With A Moat, One With Growth Hubbell: Fairly Priced, Primed To Outpace Market Expectations Organon: The Federal Reserve Black Swan (Rating Upgrade) For further details see: ...
2023-10-04 11:45:54 ET Summary The stock of junk-rated Organon & Co. has lost more than 40% since my first article, largely due to interest rates continuing to rise. I take a close look at the company's debt and how I think the situation will evolve until 2028 - when OGN will ...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...